首页/数据集/Table S8 from <i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

Table S8 from <i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

NIAID Data Ecosystem2026-05-01 收录

数据链接：

https://figshare.com/articles/dataset/Table_S8_from_i_De_Novo_i_Purine_Metabolism_is_a_Metabolic_Vulnerability_of_Cancers_with_Low_p16_Expression/25738350 数据链接链接失效反馈

官方服务：

资源简介：

TCGA melanoma patient data

应用场景：

创建时间：

2024-05-02

肿瘤分子靶向治疗

基因表达分析

We observed TRPM7, Mg2+ ion importing protein-coding gene, was differentially expressed even in the same cancer subtype. It indicates that Mg2+ ion concentration is different from individual to indivi

NIAID Data Ecosystem70

Additional file 4 of S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

肿瘤分子靶向治疗

基因突变分析

Additional file 4: Supplementary Table S4. Detected molecular alterations and their mutant allele frequencies at baseline in the discovery cohort.

Figshare2024-02-16 更新50

Effect of oncogene-induced transformation on metabolic enzyme core set

癌细胞重编程

癌基因功能分析

The expression levels of metabolic enzymes were estimated by MRM analysis with internal standard recombinant proteins. The analysis is performed in human diploid fibroblasts, TIG-3 cells and their der

NIAID Data Ecosystem30

Table_1_m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer.XLSX

癌症生物标志物

肿瘤分子靶向治疗

5-Methylcytosine (m5C) is a kind of methylation modification that occurs in both DNA and RNA and is present in the highly abundant tRNA and rRNA. It has an important impact on various human diseases i

NIAID Data Ecosystem50

DataSheet_1_Dual Inhibition of Ornithine Decarboxylase and A1 Adenosine Receptor Efficiently Suppresses Breast Tumor Cells.pdf

乳腺癌联合疗法

肿瘤分子靶向治疗

Personized treatment of breast cancer is still a challenge, and more treatment options for breast cancer are warranted. Combination therapies have been a highly appreciated strategy for breast cancer

NIAID Data Ecosystem40

Table S8 from <i>De Novo</i> Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression

资源简介：

相关数据集